Related references
Note: Only part of the references are listed.Role of GLP-1 and DPP-4 in diabetic nephropathy and cardiovascular disease
Usha Panchapakesan et al.
CLINICAL SCIENCE (2013)
KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update Foreword
Michael V. Rocco et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2012)
Protective Effects of GLP-1 on Glomerular Endothelium and Its Inhibition by PKCβ Activation in Diabetes
Akira Mima et al.
DIABETES (2012)
Dipeptidyl peptidase-IV is a potential molecular biomarker in diabetic kidney disease
Ai-li Sun et al.
DIABETES & VASCULAR DISEASE RESEARCH (2012)
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
S. E. Inzucchi et al.
DIABETOLOGIA (2012)
Dipeptidyl Peptidase IV Regulates Proliferation of Preglomerular Vascular Smooth Muscle and Mesangial Cells
Edwin K. Jackson et al.
HYPERTENSION (2012)
Sitagliptin add-on to low dosage sulphonylureas: efficacy and safety of combination therapy on glycaemic control and insulin secretion capacity in type 2 diabetes
S-I. Harashima et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2012)
DPP-4 Inhibition on Top of Angiotensin Receptor Blockade Offers a New Therapeutic Approach for Diabetic Nephropathy
Markus L. Alter et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2012)
Exenatide Reduces Urinary Transforming Growth Factor-beta(1) and Type IV Collagen Excretion in Patients with Type 2 Diabetes and Microalbuminuria
Hong Zhang et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2012)
Renal and Cardiac Effects of DPP-4 Inhibitors - from Preclinical Development to Clinical Research
Berthold Hocher et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2012)
GLP-1 analog liraglutide protects against oxidative stress and albuminuria in streptozotocin-induced diabetic rats via protein kinase A-mediated inhibition of renal NAD(P)H oxidases
Hari Hendarto et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2012)
Dipeptidyl Peptidase IV Inhibitor Attenuates Kidney Injury in Streptozotocin-Induced Diabetic Rats
Wei Jing Liu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Pioglitazone reduces urinary albumin excretion in renin-angiotensin system inhibitor-treated type 2 diabetic patients with hypertension and microalbuminuria: the APRIME study
Akizuki Morikawa et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2011)
Dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes: a comparative review
C. F. Deacon
DIABETES OBESITY & METABOLISM (2011)
Estimated glomerular filtration rate and albuminuria are independent predictors of cardiovascular events and death in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
P. L. Drury et al.
DIABETOLOGIA (2011)
Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes
R. Kodera et al.
DIABETOLOGIA (2011)
Sitagliptin reduces albuminuria in patients with type 2 diabetes
Sachiko Hattori
ENDOCRINE JOURNAL (2011)
Diabetic Nephropathy Amelioration by a Low-Dose Sitagliptin in an Animal Model of Type 2 Diabetes (Zucker Diabetic Fatty Rat)
Cristina Mega et al.
EXPERIMENTAL DIABETES RESEARCH (2011)
Incretin-based therapies - review of the physiology, pharmacology and emerging clinical experience
J. H. Martin et al.
INTERNAL MEDICINE JOURNAL (2011)
Acute DPP-4 inhibition modulates vascular tone through GLP-1 independent pathways
Zubair Shah et al.
VASCULAR PHARMACOLOGY (2011)
Cardiovascular effects of DPP-4 inhibition: Beyond GLP-1
Gian Paolo Fadini et al.
VASCULAR PHARMACOLOGY (2011)
DPP-4 inhibitors: What may be the clinical differentiators?
John Gerich
DIABETES RESEARCH AND CLINICAL PRACTICE (2010)
Exendin-4 stimulates proliferation of human coronary artery endothelial cells through eNOS-, PKA- and PI3K/Akt-dependent pathways and requires GLP-1 receptor
O. Erdogdu et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
Frequency of Hypoglycemia and Its Significance in Chronic Kidney Disease
Maureen F. Moen et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
The Extrapancreatic Effects of Glucagon-Like Peptide-1 and Related Peptides
Rania Abu-Hamdah et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Cardiovascular consequences of drugs used for the treatment of diabetes: potential promise of incretin-based therapies
Kiwon Ban et al.
JOURNAL OF THE AMERICAN SOCIETY OF HYPERTENSION (2009)
Peptidase substrates via global peptide profiling
Debarati M. Tagore et al.
NATURE CHEMICAL BIOLOGY (2009)
High glucose induces plasminogen activator inhibitor-1 expression through Rho/Rho-kinase-mediated NF-kappa B activation in bovine aortic endothelial cells
Hitoshi Iwasaki et al.
ATHEROSCLEROSIS (2008)
What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium?
S. C. Satchell et al.
DIABETOLOGIA (2008)
Targeted disruption of the meprin metalloproteinase β gene protects against renal ischemia-reperfusion injury in mice
John Bylander et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2008)
Disease-dependent mechanisms of albuminuria
Wayne D. Comper et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2008)
Inhibition of renal dipeptidyl peptidase IV enhances peptide YY1-36-Induced Potentiation of angiotensin II-Mediated renal vasoconstriction in spontaneously hypertensive rats
Edwin K. Jackson et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
TGF-β in renal injury and disease
Erwin P. Bottinger
SEMINARS IN NEPHROLOGY (2007)
Model of albumin reabsorption in the proximal tubule
Matthew J. Lazzara et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2007)
Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States medicare population, 1998 to 1999
RN Foley et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Vascular endothelial growth factor (VEGF) and soluble VEGF receptor FLT-1 in diabetic nephropathy
NH Kim et al.
KIDNEY INTERNATIONAL (2005)
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
P Gaede et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Cell biology of the glomerular podocyte
H Pavenstadt et al.
PHYSIOLOGICAL REVIEWS (2003)
Rosiglitazone reduces urinary albumin excretion in type II diabetes
G Bakris et al.
JOURNAL OF HUMAN HYPERTENSION (2003)
TGF-β signaling in renal disease
EP Böttinger et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study
IM Stratton et al.
BMJ-BRITISH MEDICAL JOURNAL (2000)
Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-β antibody in db/db diabetic mice
FN Ziyadeh et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Arterial hypertension, microalbuminuria, and risk of ischemic heart disease
JS Jensen et al.
HYPERTENSION (2000)
Share Paper
